Imugene Ltd: Application for quotation of securities - IMU
Imugene Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Imugene Ltd: Change of Director's Interest Notice - PH
Imugene Ltd: Notification regarding unquoted securities - IMU
Imugene Ltd: Imugene & Kincell Bio Strategic Partnership Investor Webinar
Imugene Ltd: Imugene and Kincell Bio Announce Strategic Partnership
Imugene Ltd: Notification of cessation of securities - IMU
Imugene Ltd: Notification regarding unquoted securities - IMU
Imugene Ltd: Bile Tract Cancer Study Opens after MAST High Dose Clearance
Imugene Ltd: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
Imugene Ltd: Oncolytic Virotherapy CF33 Patent Granted in China
Imugene Ltd: Imugene to present at 2024 Cholangiocarcinoma Conference
Imugene Ltd: Cleansing Notice
Imugene Ltd: Application for quotation of securities - IMU
Imugene Ltd: Phase 1 onCARlytics Trial Advances to Combination Arm
Imugene Ltd: Half Yearly Report and Accounts
Imugene Ltd: Phase 1 onCARlytics Trial Doses First Intravenous Patient
Imugene Ltd: Notice of change of interests of substantial holder - PH
Imugene Ltd: Change of Director's Interest Notice - PH
Imugene Ltd: Cleansing Notice
No Data